These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias. Bédard P; Parkes JD; Marsden CD Br Med J; 1978 Apr; 1(6118):954-6. PubMed ID: 638546 [TBL] [Abstract][Full Text] [Related]
10. The relationship between parkinsonism and tardive dyskinesia. Gerlach J Am J Psychiatry; 1977 Jul; 134(7):781-4. PubMed ID: 869056 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study. Libov I; Miodownik C; Bersudsky Y; Dwolatzky T; Lerner V J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739 [TBL] [Abstract][Full Text] [Related]
12. A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease. Herring WJ; Assaid C; Budd K; Vargo R; Mazenko RS; Lines C; Ellenbogen A; Verhagen Metman L Clin Neuropharmacol; 2017; 40(6):255-260. PubMed ID: 29059133 [TBL] [Abstract][Full Text] [Related]
13. Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disorders. Fahn S; Mayeux R J Neural Transm Suppl; 1980; (16):179-85. PubMed ID: 6933220 [TBL] [Abstract][Full Text] [Related]